NASDAQ:CLXT - Calyxt Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$20.78 +0.76 (+3.80 %)
(As of 06/18/2018 04:00 PM ET)
Previous Close$20.02
Today's Range$19.05 - $21.24
52-Week Range$9.26 - $31.89
Volume117,600 shs
Average Volume87,701 shs
Market Capitalization$560.98 million
P/E Ratio-18.55
Dividend YieldN/A
BetaN/A

About Calyxt (NASDAQ:CLXT)

Calyxt logoCalyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans. The Company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in New Brighton, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:CLXT
CUSIPN/A
Phone651-683-2807

Debt

Debt-to-Equity Ratio0.27
Current Ratio17.79
Quick Ratio17.79

Price-To-Earnings

Trailing P/E Ratio-18.55
Forward P/E Ratio-18.23
P/E GrowthN/A

Sales & Book Value

Annual Sales$510,000.00
Price / Sales1,141.68
Cash FlowN/A
Price / CashN/A
Book Value$2.08 per share
Price / Book9.99

Profitability

EPS (Most Recent Fiscal Year)($1.12)
Net Income$-25,980,000.00
Net Margins-5,930.60%
Return on Equity-60.81%
Return on Assets-46.54%

Miscellaneous

Employees35
Outstanding Shares28,020,000

Calyxt (NASDAQ:CLXT) Frequently Asked Questions

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

How were Calyxt's earnings last quarter?

Calyxt Inc (NASDAQ:CLXT) issued its earnings results on Monday, May, 7th. The company reported ($0.16) EPS for the quarter, beating the Zacks' consensus estimate of ($0.29) by $0.13. The business had revenue of $0.01 million for the quarter, compared to the consensus estimate of $0.20 million. Calyxt had a negative net margin of 5,930.60% and a negative return on equity of 60.81%. View Calyxt's Earnings History.

What price target have analysts set for CLXT?

5 brokers have issued 1-year target prices for Calyxt's stock. Their forecasts range from $22.00 to $34.25. On average, they expect Calyxt's share price to reach $29.05 in the next twelve months. View Analyst Ratings for Calyxt.

What are Wall Street analysts saying about Calyxt stock?

Here are some recent quotes from research analysts about Calyxt stock:
  • 1. According to Zacks Investment Research, "Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt, Inc. is based in New Brighton, United States. " (5/28/2018)
  • 2. Jefferies Financial Group Inc analysts commented, "CLXT’s 1st product launch, HOSO, is tracking better than expected & its high- fiber wheat product (significantly more profitable than HOSO) just received non-regulated status. In addition, recent developments around gene-editing on the global regulatory front have been positive and point to a potentially larger TAM. We continue to believe the market is underestimating the value of CLXT’s R&D pipeline and, as such, we reiterate our Buy rating & $27 PT. We remain encouraged by commentary on the HOSO commercialization progress. Mgmt’s HOSO commercialization plan continues to track in line with or better than our previous expectations. We were previously assuming ~50 contracted farmers in 2018, however the company has already contracted with “over 60” farmers thus far, representing ~$11.5K acres of CLXT’s HO soybeans (we were assuming $10K acres in 2018). In addition, farmer retention rates have been very strong (>90%) & repeat growers, on average, are planting >2x their previous acres of CLXT’s HO variety, which bodes well for a successful commercialization. The company remains engaged with about a dozen small to large food company customers on HOSO." (3/22/2018)

Are investors shorting Calyxt?

Calyxt saw a decline in short interest in May. As of May 31st, there was short interest totalling 979,568 shares, a decline of 27.4% from the May 15th total of 1,348,920 shares. Based on an average trading volume of 260,070 shares, the days-to-cover ratio is presently 3.8 days. Approximately 10.6% of the shares of the company are sold short.

Who are some of Calyxt's key competitors?

Who are Calyxt's key executives?

Calyxt's management team includes the folowing people:
  • Mr. Federico A. Tripodi, Chief Exec. Officer (Age 41)
  • Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 55)
  • Mr. Bryan W. J. Corkal, Chief Financial Officer (Age 50)
  • Simon Harnest, VP of Fin. & Investor Relations
  • Ms. Jennifer Moore, VP of Communications

When did Calyxt IPO?

(CLXT) raised $101 million in an initial public offering on Thursday, July 20th 2017. The company issued 6,100,000 shares at $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities served as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

Has Calyxt been receiving favorable news coverage?

News articles about CLXT stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Calyxt earned a news impact score of 0.05 on Accern's scale. They also assigned media coverage about the company an impact score of 47.46 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are Calyxt's major shareholders?

Calyxt's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (2.15%), Northern Trust Corp (0.20%) and Wells Fargo & Company MN (0.14%). Company insiders that own Calyxt stock include Alain Godard, Andre Choulika, Bryan WJ Corkal, Daniel F Voytas, Federico A Tripodi, Glenn R Bowers, Manoj Sahoo, Michel Arbadji, Philippe Dumont and SA Cellectis. View Institutional Ownership Trends for Calyxt.

Which institutional investors are selling Calyxt stock?

CLXT stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc. and Northern Trust Corp. Company insiders that have sold Calyxt company stock in the last year include Alain Godard, Andre Choulika, Bryan WJ Corkal, Daniel F Voytas, Federico A Tripodi, Glenn R Bowers, Manoj Sahoo and Michel Arbadji. View Insider Buying and Selling for Calyxt.

Which institutional investors are buying Calyxt stock?

CLXT stock was bought by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN. Company insiders that have bought Calyxt stock in the last two years include Philippe Dumont and SA Cellectis. View Insider Buying and Selling for Calyxt.

How do I buy shares of Calyxt?

Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $20.78.

How big of a company is Calyxt?

Calyxt has a market capitalization of $560.98 million and generates $510,000.00 in revenue each year. The company earns $-25,980,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. Calyxt employs 35 workers across the globe.

How can I contact Calyxt?

Calyxt's mailing address is 600 COUNTY ROAD D WEST SUITE 8, NEW BRIGHTON MN, 55112. The company can be reached via phone at 651-683-2807 or via email at [email protected]


MarketBeat Community Rating for Calyxt (CLXT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  102 (Vote Outperform)
Underperform Votes:  102 (Vote Underperform)
Total Votes:  204
MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote "Outperform" if you believe CLXT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLXT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.